Literature DB >> 34994895

ASO Author Reflections: Optimal Region of Lymph Node Dissection in Distal Pancreatectomy for Pancreatic Cancer Based on Tumor Location: Should We Dissect Non-Peripancreatic Lymph Nodes for all Left-Sided Pancreatic Cancer Patients?

Hiroyuki Ishida1,2, Toshiro Ogura3,4, Amane Takahashi1.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 34994895     DOI： 10.1245/s10434-021-11115-6

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN： 1068-9265            Impact factor:   5.344


× No keyword cloud information.
  5 in total

1.  Optimal Region of Lymph Node Dissection in Distal Pancreatectomy for Left-Sided Pancreatic Cancer Based on Tumor Location.

Authors:  Hiroyuki Ishida; Toshiro Ogura; Amane Takahashi; Ryoichi Miyamoto; Shinichi Matsudaira; Katsumi Amikura; Minoru Tanabe; Yoshiyuki Kawashima
Journal:  Ann Surg Oncol       Date:  2021-11-26       Impact factor: 5.344

2.  Reconsidering the Optimal Regional Lymph Node Station According to Tumor Location for Pancreatic Cancer.

Authors:  Taisuke Imamura; Yusuke Yamamoto; Teiichi Sugiura; Yukiyasu Okamura; Takaaki Ito; Ryo Ashida; Katsuhisa Ohgi; Katsuhiko Uesaka
Journal:  Ann Surg Oncol       Date:  2020-08-29       Impact factor: 5.344

3.  Adjuvant chemotherapy with gemcitabine and long-term outcomes among patients with resected pancreatic cancer: the CONKO-001 randomized trial.

Authors:  Helmut Oettle; Peter Neuhaus; Andreas Hochhaus; Jörg Thomas Hartmann; Klaus Gellert; Karsten Ridwelski; Marco Niedergethmann; Carl Zülke; Jörg Fahlke; Michael B Arning; Marianne Sinn; Axel Hinke; Hanno Riess
Journal:  JAMA       Date:  2013-10-09       Impact factor: 56.272

4.  Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01).

Authors:  Katsuhiko Uesaka; Narikazu Boku; Akira Fukutomi; Yukiyasu Okamura; Masaru Konishi; Ippei Matsumoto; Yuji Kaneoka; Yasuhiro Shimizu; Shoji Nakamori; Hirohiko Sakamoto; Soichiro Morinaga; Osamu Kainuma; Koji Imai; Naohiro Sata; Shoichi Hishinuma; Hitoshi Ojima; Ryuzo Yamaguchi; Satoshi Hirano; Takeshi Sudo; Yasuo Ohashi
Journal:  Lancet       Date:  2016-06-02       Impact factor: 79.321
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.